AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer

RecruitingNAAges 65 Years - anyMaleUniversity Health Network, Toronto
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

TOPCOP3 is a pilot factorial RCT of geriatric assessment and management, remote symptom monitoring, both interventions or neither, accompanied by an embedded process evaluation. This design is widely used to guide the evaluation of complex interventions and provides important data to aid design of larger RCTs. The trial itself falls within pilot trial goals including obtaining variance estimates for outcomes, assessment of recruitment potential, and understanding implementation issues vital to designing a larger trial. The investigators have clear feasibility objectives and an analytic plan as well as criteria to determine success and strong support from cancer advocacy and policy groups.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Starting an ARAT or started an ARAT within 2 weeks prior to being approached or switching ARATs due to progression or toxicity 2. Diagnosed with mPC (castration-sensitive or resistant) or nmCRPC (non-metastatic castration-resistant prostate cancer) 3. At least 65 years old 4. Able to provide written informed consent 5. Has a working telephone Exclusion Criteria: 1. Unable to speak English (as contact with the nurse interventionist is via phone, not all outcome measures are available in multiple languages) 2. Major neuropsychiatric abnormalities (severe depression or moderate-severe dementia) 3. Life expectancy \<3 months as estimated by the oncologist
๐Ÿ’Š

What it tests

  • GA+M Intervention
  • RSM intervention
  • GA+RSM intervention
๐Ÿ“

Where

3 sites
St. Michael's hospital
Toronto, Canada
University Health Network - Princess Margaret Cancer Centre
Toronto, Canada
Sunnybrook Health Sciences Centre
Toronto, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy